Management of Cutaneous Drug Reactions
Management of Cutaneous Drug Reactions
Drugs are potent chemicals that often have effects in the body beyond the desired action. These effects may range from mild and expected side effects to dramatic and life-threatening anaphylaxis. Adverse drug reactions account for between 2% and 6% of hospital admissions and may prevent administration of otherwise effective therapeutic agents. Cutaneous and mucocutaneous eruptions are the most common adverse reactions to oral or parenteral drug therapy, and the spectrum ranges from transitory exanthematous rash to the potentially fatal toxic epidermal necrolysis. Different mechanisms, including both immunologic and nonimmunologic, are responsible for cutaneous adverse drug reaction. The treatment of cutaneous drug eruptions essentially rests on accurate history, a thorough physical examination, discontinuation of the offending drug, and supportive care. The management of a cutaneous drug eruption is very much individualized, based on the clinical setting. This review aims to provide a general approach to the patient with a presumed cutaneous drug reaction.
26-33
Babu, K.S.
b21f201e-3285-4943-9347-a1a3c8727a00
Belgi, G.
17ddcd76-ce91-414d-b573-08dd4950b0d4
2002
Babu, K.S.
b21f201e-3285-4943-9347-a1a3c8727a00
Belgi, G.
17ddcd76-ce91-414d-b573-08dd4950b0d4
Babu, K.S. and Belgi, G.
(2002)
Management of Cutaneous Drug Reactions.
Current Allergy and Asthma Reports, 2, .
Abstract
Drugs are potent chemicals that often have effects in the body beyond the desired action. These effects may range from mild and expected side effects to dramatic and life-threatening anaphylaxis. Adverse drug reactions account for between 2% and 6% of hospital admissions and may prevent administration of otherwise effective therapeutic agents. Cutaneous and mucocutaneous eruptions are the most common adverse reactions to oral or parenteral drug therapy, and the spectrum ranges from transitory exanthematous rash to the potentially fatal toxic epidermal necrolysis. Different mechanisms, including both immunologic and nonimmunologic, are responsible for cutaneous adverse drug reaction. The treatment of cutaneous drug eruptions essentially rests on accurate history, a thorough physical examination, discontinuation of the offending drug, and supportive care. The management of a cutaneous drug eruption is very much individualized, based on the clinical setting. This review aims to provide a general approach to the patient with a presumed cutaneous drug reaction.
This record has no associated files available for download.
More information
Published date: 2002
Identifiers
Local EPrints ID: 8994
URI: http://eprints.soton.ac.uk/id/eprint/8994
ISSN: 1529-7322
PURE UUID: 2b9fba56-2187-4278-92df-102dfd60f55e
Catalogue record
Date deposited: 14 Sep 2004
Last modified: 08 Jan 2022 15:44
Export record
Contributors
Author:
K.S. Babu
Author:
G. Belgi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics